194 related articles for article (PubMed ID: 29088495)
1. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
[TBL] [Abstract][Full Text] [Related]
2. Effect of prednisolone on glyoxalase 1 in an inbred mouse model of aristolochic acid nephropathy using a proteomics method with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry.
Chen SM; Lin CE; Chen HH; Cheng YF; Cheng HW; Imai K
PLoS One; 2020; 15(1):e0227838. PubMed ID: 31968011
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the nephrotoxicity and safety of low-dose aristolochic acid, extending to the use of Xixin (Asurum), by determination of methylglyoxal and d-lactate.
Lin CE; Lin PY; Yang WC; Huang YS; Lin TY; Chen CM; Chen HS; Lee JA; Chen SM
J Ethnopharmacol; 2021 May; 272():113945. PubMed ID: 33617966
[TBL] [Abstract][Full Text] [Related]
4. Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.
Huang TC; Chen SM; Li YC; Lee JA
Biomed Chromatogr; 2013 Sep; 27(9):1100-6. PubMed ID: 23553367
[TBL] [Abstract][Full Text] [Related]
5. Rapid determination of aristolochic acids I and II in herbal products and biological samples by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
Kuo CH; Lee CW; Lin SC; Tsai IL; Lee SS; Tseng YJ; Kang JJ; Peng FC; Wei-Chu L
Talanta; 2010 Mar; 80(5):1672-80. PubMed ID: 20152395
[TBL] [Abstract][Full Text] [Related]
6. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.
Michl J; Jennings HM; Kite GC; Ingrouille MJ; Simmonds MS; Heinrich M
J Ethnopharmacol; 2013 Aug; 149(1):235-44. PubMed ID: 23806867
[TBL] [Abstract][Full Text] [Related]
7. [Aristolochic acid nephropathy: an issue worth more attention].
Liu XH; Yang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):554-8. PubMed ID: 23841283
[TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid nephropathy: variation in presentation and prognosis.
Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
[TBL] [Abstract][Full Text] [Related]
9. Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes.
Liu X; Liu Y; Cheng M; Xiao H
Biomarkers; 2016; 21(3):233-42. PubMed ID: 26846302
[TBL] [Abstract][Full Text] [Related]
10. Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy.
Jadot I; Colombaro V; Martin B; Habsch I; Botton O; Nortier J; Declèves AE; Caron N
PLoS One; 2017; 12(8):e0183604. PubMed ID: 28832640
[TBL] [Abstract][Full Text] [Related]
11. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a fluorogenic reagent for proteomic studies: 7-fluoro-N-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide (DAABD-F).
Koshiyama A; Imai K
Analyst; 2010 Aug; 135(8):2119-24. PubMed ID: 20539882
[TBL] [Abstract][Full Text] [Related]
13. Proteome alterations in response to aristolochic acids in experimental animal model.
Rucevic M; Rosenquist T; Breen L; Cao L; Clifton J; Hixson D; Josic D
J Proteomics; 2012 Dec; 76 Spec No.():79-90. PubMed ID: 22796065
[TBL] [Abstract][Full Text] [Related]
14. Probing the Hidden Role of Mitochondrial DNA Damage and Dysfunction in the Etiology of Aristolochic Acid Nephropathy.
Chan W; Ham YH
Chem Res Toxicol; 2021 Aug; 34(8):1903-1909. PubMed ID: 34255491
[TBL] [Abstract][Full Text] [Related]
15. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
[TBL] [Abstract][Full Text] [Related]
16. Aristolochic acid-induced accumulation of methylglyoxal and Nε-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy.
Li YC; Tsai SH; Chen SM; Chang YM; Huang TC; Huang YP; Chang CT; Lee JA
Biochem Biophys Res Commun; 2012 Jul; 423(4):832-7. PubMed ID: 22713464
[TBL] [Abstract][Full Text] [Related]
17. Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies.
Gillerot G; Goffin E; Moulin P; Arlt VM; Phillips DH; Cosyns JP; Devuyst O
Kidney Int; 2003 Nov; 64(5):1883-92. PubMed ID: 14531824
[TBL] [Abstract][Full Text] [Related]
18. Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy.
Shi M; Ma L; Zhou L; Fu P
Molecules; 2016 Oct; 21(10):. PubMed ID: 27763560
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological spectrums of aristolochic acid nephropathy.
Chen D; Tang Z; Luo C; Chen H; Liu Z
Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
Chen SM; Fan MY; Tseng CC; Ho Y; Hsu KY
Toxicon; 2007 Aug; 50(2):180-8. PubMed ID: 17512963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
